drugset / Trial / NCT00892840
Multiple-Ascending Dose Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety and tolerability of BMS-820836 after multiple doses
Timeline
- Start
- 2009-05
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liafensine | Small molecule | 0.1 mg | Oral |
| Subject | Liafensine | Small molecule | 4 mg | Oral |